Overview of Antabuse^® (Disulfiram) in Radiation and Cancer Biology

References

• Siegel RL , Miller KD , Jemal A . Cancer statistics, 2017. CA Cancer J Clin . 2017;67:7–30. doi:10.3322/caac.21387 28055103
   PubMed Web of Science ®Google Scholar
• Islami F , Goding Sauer A , Miller KD , et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin . 2018;68:31–54. doi:10.3322/caac.21440 29160902
   PubMed Web of Science ®Google Scholar
• You JS , Jones PA . Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell . 2012;22:9–20. doi:10.1016/j.ccr.2012.06.008 22789535
   PubMed Web of Science ®Google Scholar
• Liu D , Wang S , Bindeman W . Clinical applications of PD-L1 bioassays for cancer immunotherapy. J Hematol Oncol . 2017;10:110. doi:10.1186/s13045-017-0479-y 28514966
   PubMed Web of Science ®Google Scholar
• Luo H , Cui Y , Song H , Mao R , Gao Q , Ge H . Should stereotactic body radiotherapy doses be adjusted according to tumor size in early-stage non-small-cell lung cancer? A systematic review and meta-analysis. Future Oncol . 2019;15:3071–3079. doi:10.2217/fon-2019-0240 31426674
   PubMed Web of Science ®Google Scholar
• Li J , Yuan Y , Yang F , et al. Expert consensus on multidisciplinary therapy of colorectal cancer with lung metastases (2019 edition). J Hematol Oncol . 2019;12:16. doi:10.1186/s13045-019-0702-0 30764882
   PubMed Web of Science ®Google Scholar
• Collins FS . Mining for therapeutic gold. Nat Rev Drug Discov . 2011;10:397. doi:10.1038/nrd3461 21629277
   PubMed Web of Science ®Google Scholar
• Iljin K , Ketola K , Vainio P , et al. High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth. Clin Cancer Res . 2009;15:6070–6078. doi:10.1158/1078-0432.ccr-09-1035 19789329
   PubMed Web of Science ®Google Scholar
• Cvek B . Nonprofit drugs as the salvation of the world’s healthcare systems: the case of Antabuse (disulfiram). Drug Discov Today . 2012;17:409–412. doi:10.1016/j.drudis.2011.12.010 22192884
   PubMed Web of Science ®Google Scholar
• Dufour P , Lang JM , Giron C , et al. Sodium dithiocarb as adjuvant immunotherapy for high risk breast cancer: a randomized study. Biotherapy . 1993;6:9–12. doi:10.1007/BF01877380 8389572
   PubMedGoogle Scholar
• Skrott Z , Mistrik M , Andersen KK , et al. Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4. Nature . 2017;552:194–199. doi:10.1038/nature25016 29211715
   PubMed Web of Science ®Google Scholar
• Gandhi NM , Gopalaswamy UV , Nair C . Radiation protection by disulfiram: protection of membrane and DNA in vitro and in vivo against gamma-radiation. J Radiat Res . 2003;44:255–259. doi:10.1269/jrr.44.255 14646230
   PubMed Web of Science ®Google Scholar
• Rae C , Tesson M , Babich JW , Boyd M , Sorensen A , Mairs RJ . The role of copper in disulfiram-induced toxicity and radiosensitization of cancer cells. J Nucl Med . 2013;54:953–960. doi:10.2967/jnumed.112.113324 23616582
   PubMed Web of Science ®Google Scholar
• Cong J , Wang Y , Zhang X , et al. A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram. Cancer Lett . 2017;409:9–19. doi:10.1016/j.canlet.2017.08.028 28864067
   PubMed Web of Science ®Google Scholar
• Lee YE , Choi SA , Kwack PA , et al. Repositioning disulfiram as a radiosensitizer against atypical teratoid/rhabdoid tumor. Neuro Oncol . 2017;19:1079–1087. doi:10.1093/neuonc/now300 28340172
   PubMed Web of Science ®Google Scholar
• Tesson M , Anselmi G , Bell C , Mairs R . Cell cycle specific radiosensitisation by the disulfiram and copper complex. Oncotarget . 2017;8:65900–65916. doi:10.18632/oncotarget.19539 29029481
   PubMedGoogle Scholar
• Stromme JH , Eldjarn L . Distribution and chemical forms of diethyldithiocarbamate and tetraethylthiuram disulphide (disculfiram) in mice in relation to radioprotection. Biochem Pharmacol . 1966;15:287–297. doi:10.1016/0006-2952(66)90300-5 5911543
   PubMed Web of Science ®Google Scholar
• Ito Y , Cai H , Koizumi Y , et al. Effects of lipid composition on the transcorneal penetration of liposomes containing disulfiram, a potential anti-cataract agent, in the rabbit. Biol Pharm Bull . 2000;23:327–333. doi:10.1248/bpb.23.327 10726888
   PubMed Web of Science ®Google Scholar
• Taylor RD , Maners AW , Salari H , Baker M , Walker EM Jr . Disulfiram as a radiation modifier. Ann Clin Lab Sci . 1986;16:443–449.3800300
   PubMed Web of Science ®Google Scholar
• Wang HH , Cui YL , Zaorsky NG , et al. Mesenchymal stem cells generate pericytes to promote tumor recurrence via vasculogenesis after stereotactic body radiation therapy. Cancer Lett . 2016;375:349–359. doi:10.1016/j.canlet.2016.02.033 26996301
   PubMed Web of Science ®Google Scholar
• Luo H , Ge H , Cui Y , et al. Systemic inflammation biomarkers predict survival in patients of early stage non-small cell lung cancer treated with stereotactic ablative radiotherapy - a single center experience. J Cancer . 2018;9:182–188. doi:10.7150/jca.21703 29290784
   PubMed Web of Science ®Google Scholar
• Allensworth JL , Evans MK , Bertucci F , et al. Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer. Mol Oncol . 2015;9:1155–1168. doi:10.1016/j.molonc.2015.02.007 25769405
   PubMed Web of Science ®Google Scholar
• Schmitt SM , Frezza M , Dou QP . New applications of old metal-binding drugs in the treatment of human cancer. Front Biosci (Schol Ed) . 2012;4:375–391. doi:10.2741/s274 22202066
   PubMedGoogle Scholar
• Chen D , Cui QC , Yang H , Dou QP . Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity. Cancer Res . 2006;66:10425–10433. doi:10.1158/0008-5472.can-06-2126 17079463
   PubMed Web of Science ®Google Scholar
• Ma L , Zou X , Chen W . A new X-ray activated nanoparticle photosensitizer for cancer treatment. J Biomed Nanotechnol . 2014;10:1501–1508. doi:10.1166/jbn.2014.1954 25016650
   PubMed Web of Science ®Google Scholar
• Chang Y , Wu F , Pandey NK , et al. Combination of disulfiram and copper–cysteamine nanoparticles for an enhanced antitumor effect on esophageal cancer. ACS Appl Bio Mater . 2020;3:7147–7157. doi:10.1021/acsabm.0c00949
   PubMedGoogle Scholar
• Powell S , McMillan TJ . DNA damage and repair following treatment with ionizing radiation. Radiother Oncol . 1990;19:95–108. doi:10.1016/0167-8140(90)90123-e 2255771
   PubMed Web of Science ®Google Scholar
• Diehn M , Cho RW , Lobo NA , et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature . 2009;458:780–783. doi:10.1038/nature07733 19194462
   PubMed Web of Science ®Google Scholar
• Bruning A , Kast RE . Oxidizing to death: disulfiram for cancer cell killing. Cell Cycle . 2014;13:1513–1514. doi:10.4161/cc.28959 24759086
   PubMed Web of Science ®Google Scholar
• Lin PS , Kwock L , Butterfield CE . Diethyldithiocarbamate enhancement of radiation and hyperthermic effects on Chinese hamster cells in vitro. Radiat Res . 1979;77:501–511. doi:10.2307/3575161 220663
   PubMed Web of Science ®Google Scholar
• Yao W , Qian X , Ochsenreither S , et al. Disulfiram acts as a potent radio-chemo sensitizer in head and neck squamous cell carcinoma cell lines and transplanted xenografts. Cells . 2021:10. doi:10.3390/cells10030517.
   PubMed Web of Science ®Google Scholar
• Park YM , Go YY , Shin SH , Cho JG , Woo JS , Song JJ . Anti-cancer effects of disulfiram in head and neck squamous cell carcinoma via autophagic cell death. PLoS One . 2018;13:e0203069. doi:10.1371/journal.pone.0203069 30212479
   PubMed Web of Science ®Google Scholar
• Qiu C , Zhang X , Huang B , et al. Disulfiram, a ferroptosis inducer, triggers lysosomal membrane permeabilization by up-regulating ROS in Glioblastoma. Onco Targets Ther . 2020;13:10631–10640. doi:10.2147/OTT.S272312 33116640
   PubMed Web of Science ®Google Scholar
• Pajonk F , Vlashi E , McBride WH . Radiation resistance of cancer stem cells: the 4 R’s of radiobiology revisited. Stem Cells . 2010;28:639–648. doi:10.1002/stem.318 20135685
   PubMed Web of Science ®Google Scholar
• Marchitti SA , Brocker C , Stagos D , Vasiliou V . Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily. Expert Opin Drug Metab Toxicol . 2008;4:697–720. doi:10.1517/17425255.4.6.697 18611112
   PubMed Web of Science ®Google Scholar
• Huang EH , Hynes MJ , Zhang T , et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res . 2009;69:3382–3389. doi:10.1158/0008-5472.can-08-4418 19336570
   PubMed Web of Science ®Google Scholar
• Choi SA , Lee JY , Phi JH , et al. Identification of brain tumour initiating cells using the stem cell marker aldehyde dehydrogenase. Eur J Cancer . 2014;50:137–149. doi:10.1016/j.ejca.2013.09.004 24103144
   PubMed Web of Science ®Google Scholar
• Suh JJ , Pettinati HM , Kampman KM , O’Brien CP . The status of disulfiram: a half of a century later. J Clin Psychopharmacol . 2006;26:290–302. doi:10.1097/01.jcp.0000222512.25649.08 16702894
   PubMed Web of Science ®Google Scholar
• Choi SA , Choi JW , Wang KC , et al. Disulfiram modulates stemness and metabolism of brain tumor initiating cells in atypical teratoid/rhabdoid tumors. Neuro Oncol . 2015;17:810–821. doi:10.1093/neuonc/nou305 25378634
   PubMed Web of Science ®Google Scholar
• Wang Y , Li W , Patel SS , et al. Blocking the formation of radiation-induced breast cancer stem cells. Oncotarget . 2014;5:3743–3755. doi:10.18632/oncotarget.1992 25003837
   PubMedGoogle Scholar
• Nandi D , Tahiliani P , Kumar A , Chandu D . The ubiquitin-proteasome system. J Biosci . 2006;31:137–155. doi:10.1007/BF02705243 16595883
   PubMed Web of Science ®Google Scholar
• McBride WH , Iwamoto KS , Syljuasen R , Pervan M , Pajonk F . The role of the ubiquitin/proteasome system in cellular responses to radiation. Oncogene . 2003;22:5755–5773. doi:10.1038/sj.onc.1206676 12947384
   PubMed Web of Science ®Google Scholar
• Ahmed KM , Li JJ . NF-kappa B-mediated adaptive resistance to ionizing radiation. Free Radic Biol Med . 2008;44:1–13. doi:10.1016/j.freeradbiomed.2007.09.022 17967430
   PubMed Web of Science ®Google Scholar
• Lun X , Wells JC , Grinshtein N , et al. Disulfiram when combined with copper enhances the therapeutic effects of temozolomide for the treatment of glioblastoma. Clin Cancer Res . 2016;22:3860–3875. doi:10.1158/1078-0432.ccr-15-1798 27006494
   PubMed Web of Science ®Google Scholar
• Riha R , Gupta-Saraf P , Bhanja P , Badkul S , Saha S . Stressed out - therapeutic implications of ER stress related cancer research. Oncomedicine . 2017;2:156–167. doi:10.7150/oncm.22477 29445586
   PubMedGoogle Scholar
• Koizumi M , Tanjung NG , Chen A , et al. Administration of salubrinal enhances radiation-induced cell death of SW1353 chondrosarcoma cells. Anticancer Res . 2012;32:3667–3673.22993304
   PubMed Web of Science ®Google Scholar
• Hassani S , Ghaffari P , Chahardouli B , et al. Disulfiram/copper causes ROS levels alteration, cell cycle inhibition, and apoptosis in acute myeloid leukaemia cell lines with modulation in the expression of related genes. Biomed Pharmacother . 2018;99:561–569. doi:10.1016/j.biopha.2018.01.109 29902866
   PubMed Web of Science ®Google Scholar
• Paranjpe A , Zhang R , Ali-Osman F , Bobustuc GC , Srivenugopal KS . Disulfiram is a direct and potent inhibitor of human O6-methylguanine-DNA methyltransferase (MGMT) in brain tumor cells and mouse brain and markedly increases the alkylating DNA damage. Carcinogenesis . 2014;35:692–702. doi:10.1093/carcin/bgt366 24193513
   PubMed Web of Science ®Google Scholar
• Li Y , Fu SY , Wang LH , et al. Copper improves the anti-angiogenic activity of disulfiram through the EGFR/Src/VEGF pathway in gliomas. Cancer Lett . 2015;369:86–96. doi:10.1016/j.canlet.2015.07.029 26254539
   PubMed Web of Science ®Google Scholar